Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Comment by Smokey1958on Mar 15, 2021 6:14pm
158 Views
Post# 32804224

RE:What do you guys think

RE:What do you guys think

For the most part this is definitely one of the more sensible boards, Nutrader. The responses from Gal and Art are an example of that.

Another way of looking at your question is where has the company come from, where is it and what is it going to look like at the end of 2021 both operationally and financially.

In a recent post I presented the quarterly financials. From 2019 to Q2 2020 Empower had increased  quarter over quarter revenues by 500%. At that stage you could have called this a company that could generate annual revenues somewhere between $3 million and $4 million. They had a slight downturn in Q3 2020 but then acquired Kai Medical.

The financials for Kai Mecical pre the website are going to take that proposed annual return and turn it into a quarterly return ....if not even better. So all of a sudden, and with a status quo of patients using the clinics in the US, you're now looking at a company with annual revenues in the $10 million to $15 million range.

While the requirement for covid tests will logically diminish in the next one to two years the expansion of Kai Mecical is "forever". All in It was purchased for the equivalent of $2 million US. It never was nor will it ever be just a covid test analysis site.

Then the clinics??? My late father was an electrical contractor ....I understand what you're saying about bringing that all together. If, as Steve has suggested, they have a system in place to develop these is it possible that because these are reconstructions as opposed to full on building construction (from the ground up) that getting smaller firms for each trade will be easier .....and that his timeline might be easily met? Your thoughts?

As for the shock and awe, there definitely appears to be a larger contingent of traders that want Freedom 55 at 30  ....and that definitely drives volatility. It still seems though, that the bulk of traders are long on stocks 6 months to 2 years. That reality combined with the opening of 3 to 4 new clinics per quarter should be enough to drive the sp to the $5.00 target that some have suggested for the end of 2021 into the first part of 2022. 

All of this presumes there will be no more acquisitions. Steve has regularly stated just opposite. Those too will drive up revenue and one would expect the sp.

Cheers!

<< Previous
Bullboard Posts
Next >>